Cargando…

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review

This review aims to provide an overview of pre-transplant antifibrotic therapy on peri-transplant outcomes and to address the possible role of antifibrotics in lung transplant recipients with chronic lung allograft dysfunction. Lung transplantation is an established treatment modality for patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bos, Saskia, De Sadeleer, Laurens J., Vanstapel, Arno, Beeckmans, Hanne, Sacreas, Annelore, Yserbyt, Jonas, Wuyts, Wim A., Vos, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488241/ https://www.ncbi.nlm.nih.gov/pubmed/34415849 http://dx.doi.org/10.1183/16000617.0050-2021

Ejemplares similares

Aspergillus-Specific IgG Antibodies are Associated With Fungal-Related Complications and Chronic Lung Allograft Dysfunction After Lung Transplantation
por: Beeckmans, Hanne, et al.
Publicado: (2023)

Lung Transplantation and Precision Medicine
por: Beeckmans, Hanne, et al.
Publicado: (2019)

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
por: Delanote, Isabelle, et al.
Publicado: (2016)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
por: De Sadeleer, Laurens J., et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome
por: Goos, Tinne, et al.
Publicado: (2022)

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
por: Goos, Tinne, et al.
Publicado: (2021)

Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation
por: Kaes, Janne, et al.
Publicado: (2020)

Effector immune cells in chronic lung allograft dysfunction: A systematic review
por: Bos, Saskia, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report
por: Beeckmans, Hanne, et al.
Publicado: (2022)

Radiologic and histologic correlates of early interstitial lung changes in explant lungs
por: Verleden, Stijn E., et al.
Publicado: (2023)

Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle
por: Bos, Saskia, et al.
Publicado: (2022)

Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis
por: Vanstapel, Arno, et al.
Publicado: (2021)

Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study
por: De Sadeleer, Laurens J., et al.
Publicado: (2018)

Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

The common rejection module in chronic rejection post lung transplantation
por: Sacreas, Annelore, et al.
Publicado: (2018)

COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT
por: Geudens, Vincent, et al.
Publicado: (2023)

Quantitative analysis of airway obstruction in lymphangioleiomyomatosis
por: Verleden, Stijn E., et al.
Publicado: (2020)

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
por: Suwara, Monika I, et al.
Publicado: (2014)

A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome
por: Van Slambrouck, Jan, et al.
Publicado: (2022)

Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: A propensity-matched study
por: Breuls, Sofie, et al.
Publicado: (2022)

Flow-controlled ventilation during EVLP improves oxygenation and preserves alveolar recruitment
por: Ordies, Sofie, et al.
Publicado: (2020)

Lung retransplantation for chronic lung allograft dysfunction
por: Kosiorowska, Monika, et al.
Publicado: (2019)

Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD)
por: Brun, Anne-Laure, et al.
Publicado: (2021)

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts
por: Pison, Christophe, et al.
Publicado: (2023)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
por: Yoshiyasu, Nobuyuki, et al.
Publicado: (2020)

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients
por: Ramendra, Rayoun, et al.
Publicado: (2023)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

ALEMTUZUMAB FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION
por: Girgis, Reda, et al.
Publicado: (2020)

An update on chronic lung allograft dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2020)

Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation
por: Ehrsam, Jonas Peter, et al.
Publicado: (2022)

Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
por: Ram, Sundaresh, et al.
Publicado: (2022)

Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases
por: Cortesi, Emanuela E., et al.
Publicado: (2021)

Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
por: Veraar, Cecilia, et al.
Publicado: (2021)

Molecular monitoring of lung allograft health: is it ready for routine clinical use?
por: Pradère, Pauline, et al.
Publicado: (2023)

Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

Infectious Triggers of Chronic Lung Allograft Dysfunction
por: Gregson, Aric L.
Publicado: (2016)

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pqui0p9fkli17aknp3ppkln8g